• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • R&D programs and partnerships
      • MIMLIVEROnChip
      • NEUROCELL3D
      • ONCO3D
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
    • How to buy BIOMIMESYS®?
  • Assay Services
    • Dermocosmetology
      • Anti-Aging
      • Slimming
      • Anti-Oxidant
      • Anti-Redness
      • Wound Healing
      • Skin Pigmentation
      • Anti-Pollution
      • Skin Microbiota
      • Custom Your Assay In Dermocosmetics
    • Pharmacology
      • Custom Your 3D Phenotypic Assay In Oncology
      • 3D Parkinson’s Disease
      • Migration
      • Cell cycle arrest
      • 3D Screening against Liver Cancer
      • Anti-colon Cancer Drug Assessment In 3D
    • Toxicology
      • 3D Neurotoxicity Assessment
  • Ressources
    • Publications – Scientific articles
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificates of Analysis
    • TDS&MSDS
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us?
    • How to buy BIOMIMESYS®?
    • Subscribe to our Newsletter
    • Join Us

japan

Our news

First week of business trip in Asia for Nathalie Maubon (HCS Pharma)

Currently in Japan, it’s already been a week in Asia. Time goes by very quickly with 3 days of events, many appointments, visits from potential partners, a visit to the Kobe biopark and JETRO, and work appointments with our privileged partner, AS ONE.The 3 days in IDDST 2023 events in Read more…

By Nathalie MAUBON, 5 monthsMay 16, 2023 ago
Biomimesys

One month-business trip in Asia (Japan, Singapore, Taiwan)

In order to make known BIOMIMESYS technology, Grégory and Nathalie were in Asia in October during one month. The first step was in Japan. We have worked with our partners from AS ONE and JVC Kenwood. We had the opportunity to visit them in AS ONE office in order to Read more…

By Nathalie MAUBON, 9 monthsJanuary 3, 2023 ago
Biomimesys

Meet us in BIOJAPAN 2022!

It will be a pleasure to meet you in the next BIOJAPAN (Oct 12 – 14 2022) that will take place in Yakoama. We will be present on our partner’s booth, AS ONE corp. (H29). Thanks to our partners in Asia, AS ONE corp. and JVC Kenwood corp. and our Read more…

By Grégory MAUBON, 12 monthsOctober 11, 2022 ago
Biomimesys

JVCKENWOOD Corporation and HCS Pharma announce a marketing alliance to sell BIOMIMESYS® technology

We are very please to announce a marketing alliance with the Japanese company JVCKENWOOD Corporation in order to distribute all BIOMIMESYS® products in Japan and some parts of Asia. We are honored to work with a such famous brand. JVCKENWOOD will begin developing sales of HCS Pharma products through collaboration Read more…

By Grégory MAUBON, 2 yearsNovember 30, 2021 ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • HCS Pharma at 8th Bioproduction congress in Lyon on october 4-6 2023
  • Feedback of Rania’s internship about the development of primary human hepatocyte model in biochip microfludic system
  • Join us in Paris at Cosmetic 360, October 18 and 19
  • Nathalie Maubon in China on the 27th of September for the life science summit
  • HCS Pharma @ELRIG congress in Basel “Advancements in cell & gene therapy: new therapeutic horizons” on Friday, 15th september 2023
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain brain cancer cell congress cosmetology dermocosmetology drug Drug discovery ECM ELRIG event extracellular matrix genotoxicity HCS hcs pharma High content screening hydroscaffold imaging innovation in vitro in vitro models liver meeting Microbiota microscopy Molecular Devices NEUROCELL3D neurotoxicity ONCO3D oncology organoids Parkinson phenotypic screening picture poster R&D screening skin toxicology webinar
  • Company
  • BIOMIMESYS®
  • Assay Services
  • Ressources
  • Contacts
HCS Pharma (c) 2021 | Hestia | Powered by WordPress
 

Loading Comments...